Xavier García-Moll. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute Coronary Syndrome/bloodAtherosclerosis/etiologyBiometryDyslipidemias/drug therapyFluorobenzenes/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypertension/drug therapyHypoglycemic Agents/therapeutic useInflammation/drug therapyMetformin/therapeutic useOxidative Stress/drug effectsPyrimidines/therapeutic useRisk FactorsRosuvastatin CalciumSulfonamides/therapeutic useTumor Necrosis Factor-alpha/blood
Substances: See more » FluorobenzenesHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsPyrimidinesSulfonamidesTumor Necrosis Factor-alphaRosuvastatin CalciumMetformin
Year: 2007 PMID: 18082085 DOI: 10.1157/13113925
Source DB: PubMed Journal: Rev Esp Cardiol ISSN: 0300-8932 Impact factor: 4.753